Anti-CD20 antibody-related pyoderma gangrenosum

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-024-62495-z
中图分类号
学科分类号
摘要
引用
收藏
页码:2 / 2
相关论文
共 50 条
  • [31] THE EFFECT OF ANTI-CD20 ANTIBODY TREATMENT IN CYNOMOLGUS MONKEYS.
    Park, Hyojun
    Kwon, Yeongbeen
    Lee, Kyo Won
    Park, Jae Berm
    Kim, Sung Joo
    Kim, Kaabsoo
    Lee, Sanghoon
    Lee, Suk Koo
    TRANSPLANTATION, 2015, 99 (11) : S196 - S196
  • [32] Role of anti-CD20 monoclonal antibody in association with immunomodulatory agents
    Bosly, A
    PATHOLOGIE BIOLOGIE, 2004, 52 (01): : 39 - 42
  • [33] Treatment of refractory pemphigus with the anti-CD20 monoclonal antibody (rituximab)
    Marzano, Angelo V.
    Fanoni, Daniele
    Venegoni, Luigia
    Berti, Emilio
    Caputo, Ruggero
    DERMATOLOGY, 2007, 214 (04) : 310 - 318
  • [34] Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance
    Smith, MR
    ONCOGENE, 2003, 22 (47) : 7359 - 7368
  • [35] Anti-CD20 Antibody Therapy for B-Cell Lymphomas
    Maloney, David G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (21): : 2008 - 2016
  • [36] Anti-CD20 Antibody in Primary Sjogren's Syndrome Management
    Chen, Shiju
    Liu, Yuan
    Shi, Guixiu
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2014, 15 (06) : 535 - 541
  • [37] Generation of a Potent Recombinant Homophilic Chimeric Anti-CD20 Antibody
    Kohler, Heinz
    Rector, Kyle
    Amick, Jean
    HYBRIDOMA, 2012, 31 (06): : 395 - 402
  • [38] Anti-CD20 antibody treatment of non-Hodgkin lymphomas
    Engelhard, Marianne
    CLINICAL IMMUNOLOGY, 2016, 172 : 101 - 104
  • [39] Current clinical trials of the anti-CD20 monoclonal antibody rituximab
    不详
    ONCOLOGY-NEW YORK, 2000, 14 (10): : 1437 - +
  • [40] Treatment of pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab)
    Herrmann, G
    Engert, A
    Hunzelmann, N
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 148 (03) : 602 - 603